Naloxone auto-injector 10 MG production
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2290008
- Awardee
-
Kaleo, Inc. UEI LBM4GLJNDK31
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $74,177,655.45
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
This Other Transaction Indefinite Delivery Vehicle (IDV), awarded to Kaleo, Inc. on August 15, 2022, establishes a multiple-award procurement mechanism with a ceiling value of $74.2 million for the production and supply of Food and Drug Administration-approved naloxone auto-injector 10 milligram devices. The IDV is funded by the Joint Program Executive Office for Chemical and Biological Defense, a defense-focused organization within the Department of the Army. No small business set-aside was applied to this procurement vehicle. As a Multiple Award IDV, this contract structure allows the government to issue task orders against the established ceiling to meet ongoing requirements for naloxone auto-injectors, supporting national preparedness initiatives and defense-related countermeasure stockpiling objectives.
Kaleo, Inc., a specialized pharmaceutical manufacturer with established expertise in auto-injector technologies since its registration with the System for Award Management in 2009, serves as the prime contractor for this vehicle. The company's demonstrated capability in producing critical auto-injector devices for life-saving medications positions it to deliver the naloxone auto-injectors required under this IDV. Naloxone auto-injectors are essential medical countermeasures used in opioid overdose response scenarios and represent a critical component of chemical and biological defense preparedness strategy. Under this IDV structure, the government maintains the flexibility to issue task orders as requirements emerge, enabling responsive procurement of these medical devices while maintaining predictable supply from a qualified, experienced contractor capable of meeting pharmaceutical manufacturing standards and federal quality assurance requirements.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$172,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $4,000,000 | |
| Exercise an Option | $4,000,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $4,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,125,887 |
Quick answers
Who was awarded contract W911SR2290008?
W911SR2290008 was awarded to Kaleo, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on August 15, 2022.
How much is contract W911SR2290008 worth?
W911SR2290008's own ceiling is $74,177,655.
Which agency awarded contract W911SR2290008?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2290008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2290008 competed?
The extent of competition for W911SR2290008 was not competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV